 | |
| Clinical data | |
|---|---|
| Other names | 3,9,15-Trihydroxyhetisan-2-yl benzoate |
| Drug class | μ-Opioid receptor positive allosteric modulator or agonist; Analgesic |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| ChEBI | |
| Chemical and physical data | |
| Formula | C27H31NO5 |
| Molar mass | 449.547 g·mol |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
Ignavine is a naturally occurring diterpene alkaloid found in Aconiti tuber. It has been reported to act as a μ-opioid receptor (MOR) positive allosteric modulator (PAM). The drug potentiated responses to the selective MOR agonist DAMGO at low concentrations but inhibited DAMGO at high concentrations. Ignavine alone has been found to produce analgesic effects in animals, but with a biphasic dose–response curve. Although described as a MOR PAM, other research suggests that ignavine is a ligand of the orthosteric site of the MOR and does not act as a PAM. Instead, it may be a MOR partial agonist. However, more research is necessary to clarify its MOR actions. Ignavine was first isolated by 1952 and its reported MOR PAM activity was first reported by 2016.
See also
References
- ^ Livingston KE, Traynor JR (July 2018). "Allostery at opioid receptors: modulation with small molecule ligands". Br J Pharmacol. 175 (14): 2846–2856. doi:10.1111/bph.13823. PMC 6016636. PMID 28419415.
- ^ Remesic M, Hruby VJ, Porreca F, Lee YS (June 2017). "Recent Advances in the Realm of Allosteric Modulators for Opioid Receptors for Future Therapeutics". ACS Chem Neurosci. 8 (6): 1147–1158. doi:10.1021/acschemneuro.7b00090. PMC 5689070. PMID 28368571.
- ^ Kaye AD, Cornett EM, Patil SS, Gennuso SA, Colontonio MM, Latimer DR, Kaye AJ, Urman RD, Vadivelu N (June 2018). "New opioid receptor modulators and agonists". Best Pract Res Clin Anaesthesiol. 32 (2): 125–136. doi:10.1016/j.bpa.2018.06.009. PMID 30322454.
- ^ Badal S, Turfus S, Rajnarayanan R, Wilson-Clarke C, Sandiford SL (April 2018). "Analysis of natural product regulation of opioid receptors in the treatment of human disease". Pharmacol Ther. 184: 51–80. doi:10.1016/j.pharmthera.2017.10.021. PMID 29097308.
- ^ Saito H, Ueyama T, Naka N, Yagi J, Okamoto T (May 1982). "Pharmacological studies of ignavine, an aconitum alkaloid". Chem Pharm Bull (Tokyo). 30 (5): 1844–1850. doi:10.1248/cpb.30.1844. PMID 7116516.
- ^ Ohbuchi K, Miyagi C, Suzuki Y, Mizuhara Y, Mizuno K, Omiya Y, Yamamoto M, Warabi E, Sudo Y, Yokoyama A, Miyano K, Hirokawa T, Uezono Y (August 2016). "Ignavine: a novel allosteric modulator of the μ opioid receptor". Sci Rep. 6: 31748. Bibcode:2016NatSR...631748O. doi:10.1038/srep31748. PMC 4987652. PMID 27530869.